시장조사 보고서 : 세계의 재조합 단백질 시장예측 2021년-2026년

■ 영문 제목 : Global Recombinant Proteins Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02543 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 111 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료장치

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 재조합 단백질의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (인자, 재조합 대사 효소, 면역 관문 조절제, 기타)와 용도별 시장규모 (바이오 의약품 기업, 학술 연구 기관, 위탁 연구 기관) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 재조합 단백질 시장 점유율
- 지역별 재조합 단백질 시장규모
- 주요지역의 종류별 시장규모 (인자, 재조합 대사 효소, 면역 관문 조절제, 기타)
- 주요지역의 용도별 시장규모 (바이오 의약품 기업, 학술 연구 기관, 위탁 연구 기관)
- 미주의 재조합 단백질 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 재조합 단백질 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 재조합 단백질 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 재조합 단백질 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 재조합 단백질 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Abcam PLC, R&D Systems, Miltenyi Biotec, Thermo Fisher Scientific, Sigma Aldrich Company, GE Healthcare, Lonza, Merck KGaA, ProSpec Tany TechnoGene, Eurogentec (Kaneka Corporation), PeproTech, BPS Bioscience, Reprocell, GenScript Biotech Corporation, Abnova Corporation
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Recombinant Proteins will have significant change from previous year. By the most conservative estimates of global Recombinant Proteins market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 651 million in 2020. Over the next five years the Recombinant Proteins market will register a 8.4% CAGR in terms of revenue, the global market size will reach US$ 899 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Proteins market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Proteins Market Size 2016-2026
2.1.2 Recombinant Proteins Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Recombinant Proteins Segment by Type
2.2.1 Hormones
2.2.2 Hormones
2.2.3 Cytokines
2.2.4 Plasma Protein Factor
2.2.5 Recombinant Metabolic Enzymes
2.2.6 Immune Checkpoint Regulators
2.2.7 Others
2.3 Recombinant Proteins Market Size by Type
2.3.1 Global Recombinant Proteins Market Size CAGR by Type
2.3.2 Global Recombinant Proteins Market Size Market Share by Type (2016-2021)
2.4 Recombinant Proteins Segment by Application
2.4.1 Biopharmaceutical Companies
2.4.2 Academic and Research Institutes
2.4.3 Contract Research Organizations
2.5 Recombinant Proteins Market Size by Application
2.5.1 Global Recombinant Proteins Market Size CAGR by Application
2.5.2 Global Recombinant Proteins Market Size Market Share by Application (2016-2021)

3 Recombinant Proteins Market Size by Players
3.1 Recombinant Proteins Market Size Market Share by Players
3.1.1 Global Recombinant Proteins Revenue by Players (2019-2021E)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2019-2021E)
3.2 Global Recombinant Proteins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Recombinant Proteins by Regions
4.1 Recombinant Proteins Market Size by Regions (2016-2021)
4.2 Americas Recombinant Proteins Market Size Growth (2016-2021)
4.3 APAC Recombinant Proteins Market Size Growth (2016-2021)
4.4 Europe Recombinant Proteins Market Size Growth (2016-2021)
4.5 Middle East & Africa Recombinant Proteins Market Size Growth (2016-2021)

5 Americas
5.1 Americas Recombinant Proteins Market Size by Country (2016-2021)
5.2 Americas Recombinant Proteins Market Size by Type (2016-2021)
5.3 Americas Recombinant Proteins Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Recombinant Proteins Market Size by Region (2016-2021)
6.2 APAC Recombinant Proteins Market Size by Type (2016-2021)
6.3 APAC Recombinant Proteins Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Recombinant Proteins by Country (2016-2021)
7.2 Europe Recombinant Proteins Market Size by Type (2016-2021)
7.3 Europe Recombinant Proteins Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Recombinant Proteins by Region (2016-2021)
8.2 Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021)
8.3 Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Recombinant Proteins Market Forecast
10.1 Global Recombinant Proteins Forecast by Regions (2021-2026)
10.1.1 Global Recombinant Proteins Forecast by Regions (2021-2026)
10.1.2 Americas Recombinant Proteins Forecast
10.1.3 APAC Recombinant Proteins Forecast
10.1.4 Europe Recombinant Proteins Forecast
10.1.5 Middle East & Africa Recombinant Proteins Forecast
10.2 Americas Recombinant Proteins Forecast by Countries (2021-2026)
10.2.1 United States Recombinant Proteins Market Forecast
10.2.2 Canada Recombinant Proteins Market Forecast
10.2.3 Mexico Recombinant Proteins Market Forecast
10.2.4 Brazil Recombinant Proteins Market Forecast
10.3 APAC Recombinant Proteins Forecast by Region (2021-2026)
10.3.1 China Recombinant Proteins Market Forecast
10.3.2 Japan Recombinant Proteins Market Forecast
10.3.3 Korea Recombinant Proteins Market Forecast
10.3.4 Southeast Asia Recombinant Proteins Market Forecast
10.3.5 India Recombinant Proteins Market Forecast
10.3.6 Australia Recombinant Proteins Market Forecast
10.4 Europe Recombinant Proteins Forecast by Country (2021-2026)
10.4.1 Germany Recombinant Proteins Market Forecast
10.4.2 France Recombinant Proteins Market Forecast
10.4.3 UK Recombinant Proteins Market Forecast
10.4.4 Italy Recombinant Proteins Market Forecast
10.4.5 Russia Recombinant Proteins Market Forecast
10.5 Middle East & Africa Recombinant Proteins Forecast by Region (2021-2026)
10.5.1 Egypt Recombinant Proteins Market Forecast
10.5.2 South Africa Recombinant Proteins Market Forecast
10.5.3 Israel Recombinant Proteins Market Forecast
10.5.4 Turkey Recombinant Proteins Market Forecast
10.5.5 GCC Countries Recombinant Proteins Market Forecast
10.6 Global Recombinant Proteins Forecast by Type (2021-2026)
10.7 Global Recombinant Proteins Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Abcam PLC
11.1.1 Abcam PLC Company Information
11.1.2 Abcam PLC Recombinant Proteins Product Offered
11.1.3 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abcam PLC Main Business Overview
11.1.5 Abcam PLC Latest Developments
11.2 R&D Systems
11.2.1 R&D Systems Company Information
11.2.2 R&D Systems Recombinant Proteins Product Offered
11.2.3 R&D Systems Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 R&D Systems Main Business Overview
11.2.5 R&D Systems Latest Developments
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Information
11.3.2 Miltenyi Biotec Recombinant Proteins Product Offered
11.3.3 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Miltenyi Biotec Main Business Overview
11.3.5 Miltenyi Biotec Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Recombinant Proteins Product Offered
11.4.3 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Sigma Aldrich Company
11.5.1 Sigma Aldrich Company Company Information
11.5.2 Sigma Aldrich Company Recombinant Proteins Product Offered
11.5.3 Sigma Aldrich Company Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Sigma Aldrich Company Main Business Overview
11.5.5 Sigma Aldrich Company Latest Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Information
11.6.2 GE Healthcare Recombinant Proteins Product Offered
11.6.3 GE Healthcare Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 GE Healthcare Main Business Overview
11.6.5 GE Healthcare Latest Developments
11.7 Lonza
11.7.1 Lonza Company Information
11.7.2 Lonza Recombinant Proteins Product Offered
11.7.3 Lonza Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Lonza Main Business Overview
11.7.5 Lonza Latest Developments
11.8 Merck KGaA
11.8.1 Merck KGaA Company Information
11.8.2 Merck KGaA Recombinant Proteins Product Offered
11.8.3 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Merck KGaA Main Business Overview
11.8.5 Merck KGaA Latest Developments
11.9 ProSpec Tany TechnoGene
11.9.1 ProSpec Tany TechnoGene Company Information
11.9.2 ProSpec Tany TechnoGene Recombinant Proteins Product Offered
11.9.3 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 ProSpec Tany TechnoGene Main Business Overview
11.9.5 ProSpec Tany TechnoGene Latest Developments
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Information
11.10.2 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Offered
11.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Eurogentec (Kaneka Corporation) Main Business Overview
11.10.5 Eurogentec (Kaneka Corporation) Latest Developments
11. PeproTech
11.11.1 PeproTech Company Information
11.11.2 PeproTech Recombinant Proteins Product Offered
11.11.3 PeproTech Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 PeproTech Main Business Overview
11.11.5 PeproTech Latest Developments
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Information
11.12.2 BPS Bioscience Recombinant Proteins Product Offered
11.12.3 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 BPS Bioscience Main Business Overview
11.12.5 BPS Bioscience Latest Developments
11.13 Reprocell
11.13.1 Reprocell Company Information
11.13.2 Reprocell Recombinant Proteins Product Offered
11.13.3 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Reprocell Main Business Overview
11.13.5 Reprocell Latest Developments
11.14 GenScript Biotech Corporation
11.14.1 GenScript Biotech Corporation Company Information
11.14.2 GenScript Biotech Corporation Recombinant Proteins Product Offered
11.14.3 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 GenScript Biotech Corporation Main Business Overview
11.14.5 GenScript Biotech Corporation Latest Developments
11.15 Abnova Corporation
11.15.1 Abnova Corporation Company Information
11.15.2 Abnova Corporation Recombinant Proteins Product Offered
11.15.3 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Abnova Corporation Main Business Overview
11.15.5 Abnova Corporation Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Recombinant Proteins Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Hormones
Table 3. Major Players of Growth Factors
Table 4. Major Players of Cytokines
Table 5. Major Players of Plasma Protein Factor
Table 6. Major Players of Recombinant Metabolic Enzymes
Table 7. Major Players of Immune Checkpoint Regulators
Table 8. Major Players of Others
Table 9. Recombinant Proteins Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 10. Global Recombinant Proteins Market Size by Type (2016-2021) & ($ Millions)
Table 11. Global Recombinant Proteins Market Size Market Share by Type (2016-2021)
Table 12. Recombinant Proteins Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 13. Global Recombinant Proteins Market Size by Application (2016-2021) & ($ Millions)
Table 14. Global Recombinant Proteins Market Size Market Share by Application (2016-2021)
Table 15. Global Recombinant Proteins Revenue by Players (2019-2021E) & ($ Millions)
Table 16. Global Recombinant Proteins Revenue Market Share by Players (2019-2021E)
Table 17. Recombinant Proteins Key Players Head office and Products Offered
Table 18. Recombinant Proteins Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Recombinant Proteins Market Size by Regions 2016-2021 & ($ Millions)
Table 22. Global Recombinant Proteins Market Size Market Share by Regions 2016-2021
Table 23. Americas Recombinant Proteins Market Size by Country (2016-2021) & ($ Millions)
Table 24. Americas Recombinant Proteins Market Size Market Share by Country (2016-2021)
Table 25. Americas Recombinant Proteins Market Size by Type (2016-2021) & ($ Millions)
Table 26. Americas Recombinant Proteins Market Size Market Share by Type (2016-2021)
Table 27. Americas Recombinant Proteins Market Size by Application (2016-2021) & ($ Millions)
Table 28. Americas Recombinant Proteins Market Size Market Share by Application (2016-2021)
Table 29. APAC Recombinant Proteins Market Size by Region (2016-2021) & ($ Millions)
Table 30. APAC Recombinant Proteins Market Size Market Share by Region (2016-2021)
Table 31. APAC Recombinant Proteins Market Size by Type (2016-2021) & ($ Millions)
Table 32. APAC Recombinant Proteins Market Size Market Share by Type (2016-2021)
Table 33. APAC Recombinant Proteins Market Size by Application (2016-2021) & ($ Millions)
Table 34. APAC Recombinant Proteins Market Size Market Share by Application (2016-2021)
Table 35. Europe Recombinant Proteins Market Size by Country (2016-2021) & ($ Millions)
Table 36. Europe Recombinant Proteins Market Size Market Share by Country (2016-2021)
Table 37. Europe Recombinant Proteins Market Size by Type (2016-2021) & ($ Millions)
Table 38. Europe Recombinant Proteins Market Size Market Share by Type (2016-2021)
Table 39. Europe Recombinant Proteins Market Size by Application (2016-2021) & ($ Millions)
Table 40. Europe Recombinant Proteins Market Size Market Share by Application (2016-2021)
Table 41. Middle East & Africa Recombinant Proteins Market Size by Region (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Recombinant Proteins Market Size Market Share by Region (2016-2021)
Table 43. Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Recombinant Proteins Market Size Market Share by Type (2016-2021)
Table 45. Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021) & ($ Millions)
Table 46. Middle East & Africa Recombinant Proteins Market Size Market Share by Application (2016-2021)
Table 47. Key and Potential Regions of Recombinant Proteins
Table 48. Key Application and Potential Industries of Recombinant Proteins
Table 49. Key Challenges of Recombinant Proteins
Table 50. Key Trends of Recombinant Proteins
Table 51. Global Recombinant Proteins Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 52. Global Recombinant Proteins Market Size Market Share Forecast by Regions (2021-2026)
Table 53. Global Recombinant Proteins Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 54. Global Recombinant Proteins Market Size Market Share Forecast by Type (2021-2026)
Table 55. Global Recombinant Proteins Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 56. Global Recombinant Proteins Market Size Market Share Forecast by Application (2021-2026)
Table 57. Abcam PLC Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 58. Abcam PLC Recombinant Proteins Product Offered
Table 59. Abcam PLC Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 60. Abcam PLC Main Business
Table 61. Abcam PLC Latest Developments
Table 62. R&D Systems Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 63. R&D Systems Recombinant Proteins Product Offered
Table 64. R&D Systems Main Business
Table 65. R&D Systems Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. R&D Systems Latest Developments
Table 67. Miltenyi Biotec Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 68. Miltenyi Biotec Recombinant Proteins Product Offered
Table 69. Miltenyi Biotec Main Business
Table 70. Miltenyi Biotec Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Miltenyi Biotec Latest Developments
Table 72. Thermo Fisher Scientific Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 73. Thermo Fisher Scientific Recombinant Proteins Product Offered
Table 74. Thermo Fisher Scientific Main Business
Table 75. Thermo Fisher Scientific Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. Sigma Aldrich Company Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 78. Sigma Aldrich Company Recombinant Proteins Product Offered
Table 79. Sigma Aldrich Company Main Business
Table 80. Sigma Aldrich Company Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Sigma Aldrich Company Latest Developments
Table 82. GE Healthcare Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 83. GE Healthcare Recombinant Proteins Product Offered
Table 84. GE Healthcare Main Business
Table 85. GE Healthcare Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. GE Healthcare Latest Developments
Table 87. Lonza Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 88. Lonza Recombinant Proteins Product Offered
Table 89. Lonza Main Business
Table 90. Lonza Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Lonza Latest Developments
Table 92. Merck KGaA Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 93. Merck KGaA Recombinant Proteins Product Offered
Table 94. Merck KGaA Main Business
Table 95. Merck KGaA Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Merck KGaA Latest Developments
Table 97. ProSpec Tany TechnoGene Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 98. ProSpec Tany TechnoGene Recombinant Proteins Product Offered
Table 99. ProSpec Tany TechnoGene Main Business
Table 100. ProSpec Tany TechnoGene Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. ProSpec Tany TechnoGene Latest Developments
Table 102. Eurogentec (Kaneka Corporation) Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 103. Eurogentec (Kaneka Corporation) Recombinant Proteins Product Offered
Table 104. Eurogentec (Kaneka Corporation) Main Business
Table 105. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Eurogentec (Kaneka Corporation) Latest Developments
Table 107. PeproTech Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 108. PeproTech Recombinant Proteins Product Offered
Table 109. PeproTech Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 110. PeproTech Main Business
Table 111. PeproTech Latest Developments
Table 112. BPS Bioscience Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 113. BPS Bioscience Recombinant Proteins Product Offered
Table 114. BPS Bioscience Main Business
Table 115. BPS Bioscience Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. BPS Bioscience Latest Developments
Table 117. Reprocell Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 118. Reprocell Recombinant Proteins Product Offered
Table 119. Reprocell Main Business
Table 120. Reprocell Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Reprocell Latest Developments
Table 122. GenScript Biotech Corporation Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 123. GenScript Biotech Corporation Recombinant Proteins Product Offered
Table 124. GenScript Biotech Corporation Main Business
Table 125. GenScript Biotech Corporation Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. GenScript Biotech Corporation Latest Developments
Table 127. Abnova Corporation Details, Company Type, Recombinant Proteins Area Served and Its Competitors
Table 128. Abnova Corporation Recombinant Proteins Product Offered
Table 129. Abnova Corporation Main Business
Table 130. Abnova Corporation Recombinant Proteins Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Abnova Corporation Latest Developments
List of Figures
Figure 1. Recombinant Proteins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Proteins Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Recombinant Proteins Market Size Market Share by Type in 2020
Figure 7. Recombinant Proteins in Biopharmaceutical Companies
Figure 8. Global Recombinant Proteins Market: Biopharmaceutical Companies (2016-2021) & ($ Millions)
Figure 9. Recombinant Proteins in Academic and Research Institutes
Figure 10. Global Recombinant Proteins Market: Academic and Research Institutes (2016-2021) & ($ Millions)
Figure 11. Recombinant Proteins in Contract Research Organizations
Figure 12. Global Recombinant Proteins Market: Contract Research Organizations (2016-2021) & ($ Millions)
Figure 13. Global Recombinant Proteins Market Size Market Share by Application in 2020
Figure 14. Global Recombinant Proteins Revenue Market Share by Player in 2020
Figure 15. Global Recombinant Proteins Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Recombinant Proteins Market Size 2016-2021 ($ Millions)
Figure 17. APAC Recombinant Proteins Market Size 2016-2021 ($ Millions)
Figure 18. Europe Recombinant Proteins Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Recombinant Proteins Market Size 2016-2021 ($ Millions)
Figure 20. Americas Recombinant Proteins Market Size Market Share by Country in 2020
Figure 21. Americas Recombinant Proteins Market Size Market Share by Type in 2020
Figure 22. Americas Recombinant Proteins Market Size Market Share by Application in 2020
Figure 23. United States Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Recombinant Proteins Market Size Market Share by Regions in 2020
Figure 27. APAC Recombinant Proteins Market Size Market Share by Type in 2020
Figure 28. APAC Recombinant Proteins Market Size Market Share by Application in 2020
Figure 29. China Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Recombinant Proteins Market Size Market Share by Country in 2020
Figure 36. Europe Recombinant Proteins Market Size Market Share by Type in 2020
Figure 37. Europe Recombinant Proteins Market Size Market Share by Application in 2020
Figure 38. Germany Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Recombinant Proteins Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Recombinant Proteins Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Recombinant Proteins Market Size Market Share by Application in 2020
Figure 46. Egypt Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Recombinant Proteins Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 52. APAC Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 53. Europe Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 55. United States Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 56. Canada Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 59. China Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 60. Japan Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 61. Korea Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 63. India Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 64. Australia Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 65. Germany Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 66. France Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 67. UK Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 68. Italy Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 69. Russia Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 70. Spain Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 73. Israel Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Recombinant Proteins Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Recombinant Proteins Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 재조합 단백질 시장예측 2021년-2026년] (코드 : LPI-2201K02543) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 재조합 단백질 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 재조합 인간 인터페론 α1b 시장예측 2021년-2026년
LPI-2201K02160 / LP Information / 2021년 12월 / 본 조사보고서는 재조합 인간 인터페론 α1b의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Recombinant Human Interferon α1b will have significant change from previous year. By the most conservative estimates of global Recombinant Human Interferon α1b market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년
LPI-2201K00119 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아,...According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth...

세계의 IGY 폴리클로날 항체 시장예측 2021년-2026년
LPI-2201K00057 / LP Information / 2021년 12월 / 본 조사보고서는 IGY 폴리클로날 항체의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of IGY Polyclonal Antibodies will have significant change from previous year. By the most conservative estimates of global IGY Polyclonal Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6 million in...

세계의 연구용 IVD 시약 시장예측 2021년-2026년
LPI-2201K00311 / LP Information / 2021년 12월 / 본 조사보고서는 연구용 IVD 시약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of IVD Reagents for Research will have significant change from previous year. By the most conservative estimates of global IVD Reagents for Research market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 In Vitro 단백질 발현 시장예측 2021년-2026년
LPI-2201K00155 / LP Information / 2021년 12월 / 본 조사보고서는 In Vitro 단백질 발현의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of In Vitro Protein Expression will have significant change from previous year. By the most conservative estimates of global In Vitro Protein Expression market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...